Quercetagetin alleviates liver fibrosis in non-alcoholic fatty liver disease by promoting ferroptosis of hepatic stellate cells through GPX4 ubiquitination. The gene discussed is GPX4; the disease is metabolic dysfunction-associated steatotic liver disease.